{"transactions":[{"id":4618041,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-15T20:19:15.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":false,"shares":1263,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 12 September 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 12 September 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1263},"source":{"system":"sec-edgar","filing":"0001585364-26-000151","document":"wk-form4_1789503553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000151/wk-form4_1789503553.xml","form_type":"4"}},{"id":4618040,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-15T20:19:15.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":607,"price":13.66,"value":8291.62,"ownership":{"direct":true},"balance_after":33873,"source":{"system":"sec-edgar","filing":"0001585364-26-000151","document":"wk-form4_1789503553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000151/wk-form4_1789503553.xml","form_type":"4"}},{"id":4618039,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-15T20:19:15.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":true,"shares":1263,"price":13.66,"value":17252.58,"ownership":{"direct":true},"balance_after":34480,"source":{"system":"sec-edgar","filing":"0001585364-26-000151","document":"wk-form4_1789503553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000151/wk-form4_1789503553.xml","form_type":"4"}},{"id":736124,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-16T20:54:05.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":976,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 13 June 2026."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-13","underlying":"Ordinary Shares","underlying_shares":976},"source":{"system":"sec-edgar","filing":"0001585364-26-000097","document":"wk-form4_1781643242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000097/wk-form4_1781643242.xml","form_type":"4"}},{"id":736123,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-16T20:54:05.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":844,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on June 12 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on June 12 2027."}],"balance_after":844,"derivative":{"underlying":"Ordinary Shares","underlying_shares":844},"source":{"system":"sec-edgar","filing":"0001585364-26-000097","document":"wk-form4_1781643242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000097/wk-form4_1781643242.xml","form_type":"4"}},{"id":736122,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-16T20:54:05.000Z","date":"2026-06-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":469,"price":10.99,"value":5154.31,"ownership":{"direct":true},"balance_after":33217,"source":{"system":"sec-edgar","filing":"0001585364-26-000097","document":"wk-form4_1781643242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000097/wk-form4_1781643242.xml","form_type":"4"}},{"id":736121,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-16T20:54:05.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":976,"price":10.99,"value":10726.24,"ownership":{"direct":true},"balance_after":33686,"source":{"system":"sec-edgar","filing":"0001585364-26-000097","document":"wk-form4_1781643242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000097/wk-form4_1781643242.xml","form_type":"4"}},{"id":777020,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:59:52.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":7305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-14","underlying":"Ordinary Shares","underlying_shares":7305},"source":{"system":"sec-edgar","filing":"0001585364-26-000075","document":"wk-form4_1778878789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000075/wk-form4_1778878789.xml","form_type":"4"}},{"id":777019,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:59:52.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":16681,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on May 13 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on May 13 2027."}],"balance_after":16681,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16681},"source":{"system":"sec-edgar","filing":"0001585364-26-000075","document":"wk-form4_1778878789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000075/wk-form4_1778878789.xml","form_type":"4"}},{"id":777018,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T20:59:52.000Z","date":"2026-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":3507,"price":10.84,"value":38015.88,"ownership":{"direct":true},"balance_after":32710,"source":{"system":"sec-edgar","filing":"0001585364-26-000075","document":"wk-form4_1778878789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000075/wk-form4_1778878789.xml","form_type":"4"}},{"id":777017,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T20:59:52.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":7305,"price":10.84,"value":79186.2,"ownership":{"direct":true},"balance_after":36217,"source":{"system":"sec-edgar","filing":"0001585364-26-000075","document":"wk-form4_1778878789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536426000075/wk-form4_1778878789.xml","form_type":"4"}},{"id":837823,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T16:49:03.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":3024,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on March 13 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on March 13 2027."}],"balance_after":3024,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3024},"source":{"system":"sec-edgar","filing":"0001491874-26-000002","document":"wk-form4_1773766135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000149187426000002/wk-form4_1773766135.xml","form_type":"4"}},{"id":919354,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:16:19.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":152480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."}],"balance_after":152480,"derivative":{"underlying":"Common Stock","underlying_shares":152480},"source":{"system":"sec-edgar","filing":"0001737287-26-000007","document":"wk-form4_1770243376.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728726000007/wk-form4_1770243376.xml","form_type":"4"}},{"id":919353,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-04T22:16:19.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":539072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":539072,"derivative":{"exercise_price":1.87,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":539072},"source":{"system":"sec-edgar","filing":"0001737287-26-000007","document":"wk-form4_1770243376.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728726000007/wk-form4_1770243376.xml","form_type":"4"}},{"id":919352,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-04T22:16:19.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":24001,"price":1.76,"value":42241.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.71 to $1.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":1252795,"source":{"system":"sec-edgar","filing":"0001737287-26-000007","document":"wk-form4_1770243376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728726000007/wk-form4_1770243376.xml","form_type":"4"}},{"id":967445,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-16T15:44:39.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2140,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 12 December 2026."}],"balance_after":2140,"derivative":{"exercise_date":"2026-12-12","underlying":"Ordinary Shares","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001491874-25-000009","document":"wk-form4_1765899872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000149187425000009/wk-form4_1765899872.xml","form_type":"4"}},{"id":998839,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T15:45:37.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":14.18,"value":106350.0,"ownership":{"direct":false,"nature":"IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.16 to $14.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Geoffrey M. Parker Roth IRA."}],"balance_after":17375,"source":{"system":"sec-edgar","filing":"0001491874-25-000007","document":"wk-form4_1763135134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000149187425000007/wk-form4_1763135134.xml","form_type":"4"}},{"id":1014218,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-23T22:20:44.000Z","date":"2025-10-21","kind":"sale","planned":false,"acquired":false,"shares":36744,"price":1.2565,"value":46168.836,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to an employee stock purchase program, includes 6,000 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 and 6,000 shares of the Issuer's common stock acquired by the reporting person on September 15,2025."}],"balance_after":1276796,"source":{"system":"sec-edgar","filing":"0001737287-25-000091","document":"wk-form4_1761258041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728725000091/wk-form4_1761258041.xml","form_type":"4"}},{"id":1039297,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-09-16T16:16:53.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":1263,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 12 September 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 12 September 2026."}],"balance_after":1263,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1263},"source":{"system":"sec-edgar","filing":"0001585364-25-000146","document":"wk-form4_1758039410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000146/wk-form4_1758039410.xml","form_type":"4"}},{"id":1060209,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T12:11:04.000Z","date":"2025-08-18","kind":"purchase","planned":false,"acquired":true,"shares":4375,"price":22.9708,"value":100497.25,"ownership":{"direct":false,"nature":"IRA"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Geoffrey M. Parker Roth IRA."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4/A is being filed to correct the manner in which the Reporting Person purchased shares of Perrigo Company plc. The original Form 4, filed on August 19, 2025 (the \"Original Form 4\") reported the purchase of 4,375 shares by Mr. Parker directly, where such shares were in fact acquired indirectly by the Geoffrey M. Parker Roth IRA, as reflected in this Form 4/A. Other than as described in this footnote, there are no other changes from the Original Form 4."}],"balance_after":9875,"source":{"system":"sec-edgar","filing":"0001585364-25-000130","document":"wk-form4a_1755691860.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000130/wk-form4a_1755691860.xml","form_type":"4/A","original_submission_date":"2025-08-19"}},{"id":1061807,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-19T14:56:33.000Z","date":"2025-08-18","kind":"purchase","planned":false,"acquired":true,"shares":4375,"price":22.9708,"value":100497.25,"ownership":{"direct":true},"balance_after":33287,"source":{"system":"sec-edgar","filing":"0001585364-25-000128","document":"wk-form4_1755615389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000128/wk-form4_1755615389.xml","form_type":"4"}},{"id":1107932,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-17T18:18:53.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":976,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 13 June 2026."}],"balance_after":976,"derivative":{"exercise_date":"2026-06-13","underlying":"Ordinary Shares","underlying_shares":976},"source":{"system":"sec-edgar","filing":"0001585364-25-000107","document":"wk-form4_1750184326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000107/wk-form4_1750184326.xml","form_type":"4"}},{"id":1145312,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:34.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":false,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-25-000074","document":"wk-form4_1747410747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000074/wk-form4_1747410747.xml","form_type":"4"}},{"id":1145311,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:34.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026."}],"balance_after":7305,"derivative":{"exercise_date":"2026-05-14","underlying":"Ordinary Shares","underlying_shares":7305},"source":{"system":"sec-edgar","filing":"0001585364-25-000074","document":"wk-form4_1747410747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000074/wk-form4_1747410747.xml","form_type":"4"}},{"id":1145310,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:34.000Z","date":"2025-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4754,"price":26.01,"value":123651.54,"ownership":{"direct":true},"balance_after":28912,"source":{"system":"sec-edgar","filing":"0001585364-25-000074","document":"wk-form4_1747410747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000074/wk-form4_1747410747.xml","form_type":"4"}},{"id":1145309,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:34.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":true,"shares":9904,"price":26.01,"value":257603.04,"ownership":{"direct":true},"balance_after":33666,"source":{"system":"sec-edgar","filing":"0001585364-25-000074","document":"wk-form4_1747410747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000074/wk-form4_1747410747.xml","form_type":"4"}},{"id":1149180,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-14T18:06:42.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":27.1,"value":94850.0,"ownership":{"direct":true},"balance_after":23762,"source":{"system":"sec-edgar","filing":"0001585364-25-000058","document":"wk-form4_1747245994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536425000058/wk-form4_1747245994.xml","form_type":"4"}},{"id":1281822,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-05T21:15:47.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":4361,"price":1.73,"value":7544.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":1301540,"source":{"system":"sec-edgar","filing":"0001737287-25-000019","document":"wk-form4_1738790139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728725000019/wk-form4_1738790139.xml","form_type":"4"}},{"id":1293005,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to buy)","published_at":"2025-01-29T01:15:11.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":614844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":614844,"derivative":{"exercise_price":1.94,"expiration_date":"2035-01-24","underlying":"Common Stock","underlying_shares":614844},"source":{"system":"sec-edgar","filing":"0001737287-25-000008","document":"wk-form4_1738113304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728725000008/wk-form4_1738113304.xml","form_type":"4"}},{"id":1293004,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-29T01:15:11.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":173913,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1305901,"source":{"system":"sec-edgar","filing":"0001737287-25-000008","document":"wk-form4_1738113304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728725000008/wk-form4_1738113304.xml","form_type":"4"}},{"id":1382359,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-23T20:21:32.000Z","date":"2024-10-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":36404,"price":2.84,"value":103387.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,974 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program."}],"balance_after":1131988,"source":{"system":"sec-edgar","filing":"0001737287-24-000065","document":"wk-form4_1729714884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000173728724000065/wk-form4_1729714884.xml","form_type":"4"}},{"id":1508936,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-20T22:02:28.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":344828,"price":2.9,"value":1000001.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the \"Issuer\") in a registered direct offering."}],"balance_after":1164418,"source":{"system":"sec-edgar","filing":"0001593968-24-000715","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396824000715/primary_01.xml","form_type":"4"}},{"id":1514221,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:28:39.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-24-000090","document":"wk-form4_1715902105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536424000090/wk-form4_1715902105.xml","form_type":"4"}},{"id":1514220,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:28:39.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":9904,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-24-000090","document":"wk-form4_1715902105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536424000090/wk-form4_1715902105.xml","form_type":"4"}},{"id":1514219,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:28:39.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4207,"price":30.22,"value":127135.54,"ownership":{"direct":true},"balance_after":20262,"source":{"system":"sec-edgar","filing":"0001585364-24-000090","document":"wk-form4_1715902105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536424000090/wk-form4_1715902105.xml","form_type":"4"}},{"id":1514218,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:28:39.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":8764,"price":30.22,"value":264848.08,"ownership":{"direct":true},"balance_after":24469,"source":{"system":"sec-edgar","filing":"0001585364-24-000090","document":"wk-form4_1715902105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536424000090/wk-form4_1715902105.xml","form_type":"4"}},{"id":1591590,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-07T02:52:06.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":190,"price":3.595,"value":683.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Parker was notified by his broker on March 4, 2024 that these shares were purchased in an account held by the Geoffrey M. Parker and Jill G. Parker Rev. Trust dated January 27, 2000 for which Mr. Parker does not have discretion.  This account is intended to closely track the performance of the Russell 2000 and is frequently rebalanced by an algorithm designed by the broker which led to the purchase of these shares.  Restrictions have been now placed on all such accounts held by the Trust to avoid such purchases of the Issuer stock in the future."}],"balance_after":819590,"source":{"system":"sec-edgar","filing":"0001593968-24-000449","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396824000449/primary_01.xml","form_type":"4"}},{"id":1665120,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-31T22:47:41.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":103939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter."}],"balance_after":103939,"derivative":{"exercise_price":3.2,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":103939},"source":{"system":"sec-edgar","filing":"0001593968-24-000195","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396824000195/primary_01.xml","form_type":"4"}},{"id":1665119,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-01-31T22:47:41.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":819400,"source":{"system":"sec-edgar","filing":"0001593968-24-000195","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396824000195/primary_01.xml","form_type":"4"}},{"id":1703322,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-20T22:22:41.000Z","date":"2023-12-18","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting person was awarded 3,750 Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024."}],"balance_after":1031805,"source":{"system":"sec-edgar","filing":"0000950170-23-071958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000095017023071958/ownership.xml","form_type":"4"}},{"id":1758976,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-17T21:02:27.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on October 16, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":950000,"derivative":{"exercise_price":3.24,"expiration_date":"2033-10-16","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001593968-23-001369","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396823001369/primary_01.xml","form_type":"4"}},{"id":1758975,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-10-17T21:02:27.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Constitutes Performance Restricted Stock Units (\"PRSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each PRSU upon vesting,  50% shall vest in the event the Company achieves a 30-day weighted average share price of $18 on or before March 22, 2026 and 50% shall vest upon the first marketing approval of a Company product by the US FDA on or before March 22, 2028."}],"balance_after":790000,"source":{"system":"sec-edgar","filing":"0001593968-23-001369","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396823001369/primary_01.xml","form_type":"4"}},{"id":1758974,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"officer":true,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-10-17T21:02:27.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001593968-23-001369","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159396823001369/primary_01.xml","form_type":"4"}},{"id":1820433,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T11:58:44.000Z","date":"2023-07-27","kind":"purchase","planned":false,"acquired":true,"shares":685025,"price":0.7299,"value":499999.7475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the \"PIPE Investors\") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"As one of the PIPE Investors, the Reporting Person acquired 685,025 shares of Issuer common stock on July 27, 2023 for $0.7299 per share."}],"balance_after":1028055,"source":{"system":"sec-edgar","filing":"0000950170-23-035679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000095017023035679/ownership.xml","form_type":"4"}},{"id":1855871,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-14T14:54:49.000Z","date":"2023-06-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":33.0637,"value":330637.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Revocable trust in which Geoffrey Parker and Jill Parker are the trustees."}],"balance_after":25879,"source":{"system":"sec-edgar","filing":"0001585364-23-000106","document":"wf-form4_168675447611252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000106/wf-form4_168675447611252.xml","form_type":"4"}},{"id":1860449,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T22:55:28.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023."}],"balance_after":15000,"derivative":{"exercise_price":0.77,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-23-027334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000095017023027334/ownership.xml","form_type":"4"}},{"id":1884558,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T18:38:29.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-23-000096","document":"wf-form4_168452149168169.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000096/wf-form4_168452149168169.xml","form_type":"4"}},{"id":1884557,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:38:29.000Z","date":"2023-05-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3734,"price":32.86,"value":122699.24,"ownership":{"direct":true},"balance_after":15705,"source":{"system":"sec-edgar","filing":"0001585364-23-000096","document":"wf-form4_168452149168169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000096/wf-form4_168452149168169.xml","form_type":"4"}},{"id":1884556,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:38:29.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":7778,"price":32.86,"value":255585.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."}],"balance_after":19439,"source":{"system":"sec-edgar","filing":"0001585364-23-000096","document":"wf-form4_168452149168169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000096/wf-form4_168452149168169.xml","form_type":"4"}},{"id":1888957,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-17T19:40:59.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":8764,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-23-000075","document":"wf-form4_168435244294643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000075/wf-form4_168435244294643.xml","form_type":"4"}},{"id":1920939,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T20:15:12.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":303030,"price":0.825,"value":249999.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the \"PIPE Investors\") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share."}],"balance_after":343030,"source":{"system":"sec-edgar","filing":"0000899243-23-011188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924323011188/doc4.xml","form_type":"4"}},{"id":1965736,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-07T12:48:07.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":5000,"price":38.054,"value":190270.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Revocable trust in which Geoffrey Parker and Jill Parker are the trustees."}],"balance_after":15879,"source":{"system":"sec-edgar","filing":"0001585364-23-000008","document":"wf-form4_167819327700302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536423000008/wf-form4_167819327700302.xml","form_type":"4"}},{"id":2132969,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":15723,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132968,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":13.94,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132967,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":13352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":12.94,"underlying":"Common Stock","underlying_shares":13352},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132966,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":12287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":11.6,"underlying":"Common Stock","underlying_shares":12287},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132965,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":4504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":10.06,"underlying":"Common Stock","underlying_shares":4504},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132964,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":8342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":22.39,"underlying":"Common Stock","underlying_shares":8342},"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132963,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":false,"nature":"By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 3, 2022, among Amgen Inc. (\"Parent\"), Carnation Merger Sub, Inc. (\"Merger Sub\") and ChemoCentryx, Inc. (the \"Company\"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the \"Shares,\" and each such share, a \"Share\") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the \"Merger Consideration\"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132962,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":21076,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 3, 2022, among Amgen Inc. (\"Parent\"), Carnation Merger Sub, Inc. (\"Merger Sub\") and ChemoCentryx, Inc. (the \"Company\"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the \"Shares,\" and each such share, a \"Share\") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the \"Merger Consideration\"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2132961,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T23:08:17.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":107997,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 3, 2022, among Amgen Inc. (\"Parent\"), Carnation Merger Sub, Inc. (\"Merger Sub\") and ChemoCentryx, Inc. (the \"Company\"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the \"Shares,\" and each such share, a \"Share\") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the \"Merger Consideration\"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-034084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322034084/doc4.xml","form_type":"4"}},{"id":2232619,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T20:25:04.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":25000,"price":1.4473,"value":36182.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000899243-22-022382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322022382/doc4.xml","form_type":"4"}},{"id":2235864,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:42:24.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date.  The stock option was granted on June 9, 2022."}],"balance_after":15000,"derivative":{"exercise_price":1.66,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-021940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322021940/doc4.xml","form_type":"4"}},{"id":2251342,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T01:35:17.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option granted on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":8342,"derivative":{"exercise_price":22.39,"exercise_date":"2023-05-26","expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":8342},"source":{"system":"sec-edgar","filing":"0001209191-22-033042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122033042/doc4.xml","form_type":"4"}},{"id":2251341,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T01:35:17.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":15723,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":15723,"derivative":{"underlying":"Common Stock","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0001209191-22-033042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122033042/doc4.xml","form_type":"4"}},{"id":2258208,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-25T00:13:55.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":7726,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vested on May 20, 2022.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vested on May 20, 2022.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7726},"source":{"system":"sec-edgar","filing":"0001209191-22-031761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122031761/doc4.xml","form_type":"4"}},{"id":2258207,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T00:13:55.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":7726,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021."}],"balance_after":21076,"source":{"system":"sec-edgar","filing":"0001209191-22-031761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122031761/doc4.xml","form_type":"4"}},{"id":2263679,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:52:48.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-22-000052","document":"wf-form4_165298275391518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536422000052/wf-form4_165298275391518.xml","form_type":"4"}},{"id":2263678,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:52:48.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":7778,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-22-000052","document":"wf-form4_165298275391518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536422000052/wf-form4_165298275391518.xml","form_type":"4"}},{"id":2263677,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:52:48.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":3168,"price":38.57,"value":122189.76,"ownership":{"direct":true},"balance_after":11661,"source":{"system":"sec-edgar","filing":"0001585364-22-000052","document":"wf-form4_165298275391518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536422000052/wf-form4_165298275391518.xml","form_type":"4"}},{"id":2263676,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:52:48.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":6599,"price":38.57,"value":254523.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."}],"balance_after":14829,"source":{"system":"sec-edgar","filing":"0001585364-22-000052","document":"wf-form4_165298275391518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536422000052/wf-form4_165298275391518.xml","form_type":"4"}},{"id":2284219,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-03T14:29:57.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of May 2, 2022, and prior to this transaction, the exercised options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.42,"expiration_date":"2022-06-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-026584","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122026584/doc4.xml","form_type":"4"}},{"id":2284218,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T14:29:57.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":12500,"price":14.42,"value":180250.0,"ownership":{"direct":true},"balance_after":124413,"source":{"system":"sec-edgar","filing":"0001209191-22-026584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919122026584/doc4.xml","form_type":"4"}},{"id":2312870,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T20:38:24.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":15000,"price":2.1487,"value":32230.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.08 to $2.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000899243-22-012959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924322012959/doc4.xml","form_type":"4"}},{"id":2360527,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO and EVP"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-02T21:49:08.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":256000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 28, 2023, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date."}],"balance_after":256000,"derivative":{"exercise_price":7.96,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":256000},"source":{"system":"sec-edgar","filing":"0001595585-22-000015","document":"wf-form4_164625771128910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558522000015/wf-form4_164625771128910.xml","form_type":"4"}},{"id":2449011,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO and EVP"}}],"security":"Common Stock","published_at":"2022-01-04T21:18:17.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":1384,"price":9.56,"value":13231.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs granted on September 10, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 1,664 shares acquired on November 30, 2021 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. These acquisitions are exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B)."}],"balance_after":63617,"source":{"system":"sec-edgar","filing":"0001595585-22-000003","document":"wf-form4_164133106298138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558522000003/wf-form4_164133106298138.xml","form_type":"4"}},{"id":2466020,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-12-17T17:34:40.000Z","date":"2021-12-16","kind":"purchase","acquired":true,"shares":5000,"price":36.854,"value":184270.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Revocable trust in which Geoffrey Parker and Jill Parker are the trustees."}],"balance_after":10879,"source":{"system":"sec-edgar","filing":"0001585364-21-000122","document":"wf-form4_163976246750439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000122/wf-form4_163976246750439.xml","form_type":"4"}},{"id":2469825,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T21:32:17.000Z","date":"2021-12-14","kind":"purchase","acquired":true,"shares":20000,"price":4.94,"value":98800.0,"ownership":{"direct":false,"nature":"By Parker Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.7100 to $5.3050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the \"Parker Trust\"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust."}],"balance_after":53333,"source":{"system":"sec-edgar","filing":"0000899243-21-048609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924321048609/doc4.xml","form_type":"4"}},{"id":2507214,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO and EVP"}}],"security":"Common Warrants","published_at":"2021-11-17T21:29:21.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":166667,"ownership":{"direct":false,"nature":"By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of common stock and these common warrants were acquired directly from Tricida, Inc. (the \"Issuer\") in a registered direct offering. For each share purchased in the registered direct offering, at a price of $6.00 per share of common stock, the purchaser received one warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The common warrants may be exercised for shares of common stock at any time on or after the date that is six months after the date of their issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The expiration date is the earliest of: (a) the third anniversary of the date of their issuance, (b) immediately prior to the closing of a fundamental transaction or (c) the occurrence of certain other events. A \"fundamental transaction\" includes a consolidation or merger, the sale, transfer or other disposition of all or substantially all of the Issuer's properties or assets, the acquisition of more than 50% of the Issuer's outstanding common stock, any reorganization, recapitalization or reclassification of the Issuer's common stock or any person or group becoming the beneficial owner of 50% of the voting power represented by the Issuer's outstanding common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00."}],"balance_after":166667,"derivative":{"exercise_price":11,"underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001595585-21-000132","document":"wf-form4_163718453716271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558521000132/wf-form4_163718453716271.xml","form_type":"4"}},{"id":2507213,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO and EVP"}}],"security":"Common Stock","published_at":"2021-11-17T21:29:21.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":166667,"price":6,"value":1000002.0,"ownership":{"direct":false,"nature":"By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of common stock and these common warrants were acquired directly from Tricida, Inc. (the \"Issuer\") in a registered direct offering. For each share purchased in the registered direct offering, at a price of $6.00 per share of common stock, the purchaser received one warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00."}],"balance_after":261667,"source":{"system":"sec-edgar","filing":"0001595585-21-000132","document":"wf-form4_163718453716271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558521000132/wf-form4_163718453716271.xml","form_type":"4"}},{"id":2530641,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T00:57:52.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":28300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date.  The stock option was granted on October 28, 2021."}],"balance_after":28300,"derivative":{"exercise_price":10.97,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":28300},"source":{"system":"sec-edgar","filing":"0000899243-21-042253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924321042253/doc4.xml","form_type":"4"}},{"id":2530640,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T00:57:52.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":33333,"ownership":{"direct":false,"nature":"By Parker Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the \"Merger Agreement\"), by and among Mountain Crest Acquisition Corp. II (\"Issuer\"), MCAD Merger Sub Inc. (\"Merger Sub\") and Better Therapeutics, Inc. (\"BTX\"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the \"Merger Agreement\"), by and among Mountain Crest Acquisition Corp. II (\"Issuer\"), MCAD Merger Sub Inc. (\"Merger Sub\") and Better Therapeutics, Inc. (\"BTX\"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the \"Business Combination\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the \"Parker Trust\"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust."}],"balance_after":33333,"source":{"system":"sec-edgar","filing":"0000899243-21-042253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000089924321042253/doc4.xml","form_type":"4"}},{"id":2698884,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-25T00:09:52.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the restricted stock units vested on May 21, 2021.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"100% of the restricted stock units vested on May 21, 2021.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-21-035555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121035555/doc4.xml","form_type":"4"}},{"id":2698883,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-25T00:09:52.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":4504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":4504,"derivative":{"exercise_price":10.06,"exercise_date":"2022-05-20","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":4504},"source":{"system":"sec-edgar","filing":"0001209191-21-035555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121035555/doc4.xml","form_type":"4"}},{"id":2698882,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-25T00:09:52.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":7726,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":7726,"derivative":{"underlying":"Common Stock","underlying_shares":7726},"source":{"system":"sec-edgar","filing":"0001209191-21-035555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121035555/doc4.xml","form_type":"4"}},{"id":2698881,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T00:09:52.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 21, 2020."}],"balance_after":13350,"source":{"system":"sec-edgar","filing":"0001209191-21-035555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121035555/doc4.xml","form_type":"4"}},{"id":2698880,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T00:09:52.000Z","date":"2021-03-10","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"balance_after":8690,"source":{"system":"sec-edgar","filing":"0001209191-21-035555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121035555/doc4.xml","form_type":"4"}},{"id":2705441,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-19T16:59:28.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."}],"balance_after":6599,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-21-000085","document":"wf-form4_162144355090726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000085/wf-form4_162144355090726.xml","form_type":"4"}},{"id":2718562,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:56:54.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":5804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5804},"source":{"system":"sec-edgar","filing":"0001585364-21-000059","document":"wf-form4_162075939646305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000059/wf-form4_162075939646305.xml","form_type":"4"}},{"id":2718561,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:56:54.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":2786,"price":42.96,"value":119686.56,"ownership":{"direct":true},"balance_after":11459,"source":{"system":"sec-edgar","filing":"0001585364-21-000059","document":"wf-form4_162075939646305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000059/wf-form4_162075939646305.xml","form_type":"4"}},{"id":2718560,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:56:54.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":5804,"price":42.96,"value":249339.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."}],"balance_after":14245,"source":{"system":"sec-edgar","filing":"0001585364-21-000059","document":"wf-form4_162075939646305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000059/wf-form4_162075939646305.xml","form_type":"4"}},{"id":2779219,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-18T18:45:08.000Z","date":"2021-03-17","kind":"purchase","acquired":true,"shares":2500,"price":41.2871,"value":103217.75,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Revocable trust in which Geoffrey Parker and Jill Parker are the trustees."}],"balance_after":2650,"source":{"system":"sec-edgar","filing":"0001585364-21-000041","document":"wf-form4_161609309575917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000158536421000041/wf-form4_161609309575917.xml","form_type":"4"}},{"id":2803159,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T01:28:07.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":13330,"price":55.887,"value":744973.71,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $55.27 to $56.25 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":12690,"source":{"system":"sec-edgar","filing":"0001209191-21-018788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121018788/doc4.xml","form_type":"4"}},{"id":2803158,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T01:28:07.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":16670,"price":56.7783,"value":946494.261,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $56.26 to $57.20 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":26020,"source":{"system":"sec-edgar","filing":"0001209191-21-018788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121018788/doc4.xml","form_type":"4"}},{"id":2803157,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T01:28:07.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":1910,"price":60.1992,"value":114980.472,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $60.03 to $60.34 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":42690,"source":{"system":"sec-edgar","filing":"0001209191-21-018788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121018788/doc4.xml","form_type":"4"}},{"id":2879164,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T01:05:47.000Z","date":"2020-06-15","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust"},"balance_after":44600,"source":{"system":"sec-edgar","filing":"0001209191-21-007911","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919121007911/doc5.xml","form_type":"5"}},{"id":2902305,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-20T22:16:10.000Z","date":"2021-01-17","kind":"grant","acquired":true,"shares":216000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on January 17, 2022, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date."}],"balance_after":216000,"derivative":{"exercise_price":7.03,"expiration_date":"2031-01-16","underlying":"Common Stock","underlying_shares":216000},"source":{"system":"sec-edgar","filing":"0001595585-21-000022","document":"wf-form4_161118093167557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558521000022/wf-form4_161118093167557.xml","form_type":"4"}},{"id":2950119,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2020-12-11T00:46:37.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":15000,"price":6.78,"value":101700.0,"ownership":{"direct":false,"nature":"By Equity Trust Company, Trustee of the Geoffrey M. Parker Roth IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $6.92, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Equity Trust Company, Trustee of the Geoffrey M. Parker Roth IRA"}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001595585-20-000153","document":"wf-form4_160764758246624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558520000153/wf-form4_160764758246624.xml","form_type":"4"}},{"id":3032298,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Fin. Officer and EVP"}}],"security":"Common Stock","published_at":"2020-09-15T00:33:56.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on December 31, 2021, subject to the Reporting Person's continuous service through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 672 shares acquired on June 30, 2020 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. This acquisition is exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B)."}],"balance_after":60837,"source":{"system":"sec-edgar","filing":"0001595585-20-000121","document":"wf-form4_160013002118302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000159558520000121/wf-form4_160013002118302.xml","form_type":"4"}},{"id":3135144,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37676,"kind":"person","name":"Parker Geoffrey M.","position":1,"cik":"0001491874","reported_name":"Parker Geoffrey M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-27T00:55:26.000Z","date":"2020-05-23","kind":"exercise","acquired":false,"shares":7724,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the restricted stock units vested on May 23, 2020.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"100% of the restricted stock units vested on May 23, 2020.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7724},"source":{"system":"sec-edgar","filing":"0001209191-20-032210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491874/000120919120032210/doc4.xml","form_type":"4"}}],"next_cursor":"2020-05-27T00:55:26.000000Z,3135144"}